These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24366347)

  • 1. From molecular understanding to clinical advances.
    Lee CH; Motzer RJ
    Nat Rev Urol; 2014 Feb; 11(2):77-9. PubMed ID: 24366347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.
    Vanharanta S; Shu W; Brenet F; Hakimi AA; Heguy A; Viale A; Reuter VE; Hsieh JJ; Scandura JM; Massagué J
    Nat Med; 2013 Jan; 19(1):50-6. PubMed ID: 23223005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of renal cell cancer and the identification of therapeutic targets.
    Iliopoulos O
    J Clin Oncol; 2006 Dec; 24(35):5593-600. PubMed ID: 17158545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
    Zhang YT; Chen N; Zeng H; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.
    Staller P; Sulitkova J; Lisztwan J; Moch H; Oakeley EJ; Krek W
    Nature; 2003 Sep; 425(6955):307-11. PubMed ID: 13679920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 and renal cancer: from lab to bedside.
    Schips L; Volpe A
    Cell Cycle; 2010 Dec; 9(24):4785. PubMed ID: 21248482
    [No Abstract]   [Full Text] [Related]  

  • 9. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.
    Haase VH
    Kidney Int; 2006 Apr; 69(8):1302-7. PubMed ID: 16531988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two HIFs may be better than one.
    Seagroves T; Johnson RS
    Cancer Cell; 2002 Apr; 1(3):211-3. PubMed ID: 12086854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From genes to metabolomics in renal cell carcinoma translational research.
    Mulders PF
    Eur Urol; 2013 Feb; 63(2):252-3. PubMed ID: 23182551
    [No Abstract]   [Full Text] [Related]  

  • 13. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.
    Esteban MA; Tran MG; Harten SK; Hill P; Castellanos MC; Chandra A; Raval R; O'brien TS; Maxwell PH
    Cancer Res; 2006 Apr; 66(7):3567-75. PubMed ID: 16585181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into von Hippel-Lindau function highlighted by investigation of the trichloroethylene-induced p.P81S hotspot mutation.
    Neckers L; Ricketts CJ; Marston Linehan W
    J Natl Cancer Inst; 2013 Sep; 105(18):1339-40. PubMed ID: 23990664
    [No Abstract]   [Full Text] [Related]  

  • 16. Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL.
    Li M; Kim WY
    J Cell Mol Med; 2011 Feb; 15(2):187-95. PubMed ID: 21155973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
    Krishnamachary B; Zagzag D; Nagasawa H; Rainey K; Okuyama H; Baek JH; Semenza GL
    Cancer Res; 2006 Mar; 66(5):2725-31. PubMed ID: 16510593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actuality of Warburg's views in our understanding of renal cancer metabolism.
    Godinot C; de Laplanche E; Hervouet E; Simonnet H
    J Bioenerg Biomembr; 2007 Jun; 39(3):235-41. PubMed ID: 17665292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
    Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
    Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional significance of erythropoietin in renal cell carcinoma.
    Morais C; Johnson DW; Vesey DA; Gobe GC
    BMC Cancer; 2013 Jan; 13():14. PubMed ID: 23305401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.